Tissue-Engineering Strategies to Repair Joint Tissue in Osteoarthritis: Nonviral Gene-Transfer Approaches

Current Rheumatology Reports

Volumn 16, Issue 10, 2014, Pages

  Madry, Henning ^a   Cucchiarini, Magali ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Articular chondrocytes; Biomaterials; Bioreactor; Cartilage defects; Cartilage repair; Gene therapy; Growth factors; Mesenchymal stem cells; Nonviral; Osteoarthritis; Scaffold; Tissue engineering

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 18; FIBROBLAST GROWTH FACTOR 2; MOLECULAR SCAFFOLD; OSTEOGENIC PROTEIN 1; PLASMID VECTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICULAR CARTILAGE; BIOREACTOR; CARTILAGE CELL; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; JOINT; JOINT SURGERY; MESENCHYMAL STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSTEOARTHRITIS; REVIEW; TISSUE ENGINEERING; TISSUE REPAIR; GENE TRANSFER; GENETICS; PATHOLOGY; PROCEDURES;

CARTILAGE, ARTICULAR; GENE TRANSFER TECHNIQUES; HUMANS; OSTEOARTHRITIS; TISSUE ENGINEERING;

EID: 84906721488     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-014-0450-7     Document Type: Review

References (116)

1. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64(6):1697–707. A thorough and important review of osteoarthritis affecting the whole joint.
2. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007;213(3):626–34.
3. Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci. 2010;1192:230–7. An excellent review on the interplay between articular cartilage and subchondral bone in osteoarthritis.
4. Madry H, Luyten FP, Facchini A. Biological aspects of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2012;30(3):407–22.
5. Hunziker EB. The elusive path to cartilage regeneration. Adv Mater. 2009;21(32–33):3419–24. A key review emphasizing the many obstacles for articular cartilage regeneration.
6. Madry H, Grun UW, Knutsen G. Cartilage repair and joint preservation: medical and surgical treatment options. Dtsch Arztebl Int. 2011;108(40):669–77.
7. McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22(3):363–88. doi:10.1016/j.joca.2014.01.003.
8. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260(5110):920–6. Classical review on tissue engineering.
9. Mulligan RC. The basic science of gene therapy. Science. 1993;260:926–32. Classical review on gene therapy.
10. Evans CH. Gene therapies for osteoarthritis. Curr Rheumatol Rep. 2004;6(1):31–40.
11. Cucchiarini M, Madry H. Gene therapy for cartilage defects. J Gene Med. 2005;7(12):1495–509.
12. Cucchiarini M, Madry H. The potential of gene transfer for the treatment of osteoarthritis. Regen Med. 2013;9(1):5–8.
13. Koelling S, Kruegel J, Irmer M, Path JR, Sadowski B, Miro X, et al. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell. 2009;4(4):324–35.
14. Madry H, van Dijk CN, Mueller-Gerbl M. The basic science of the subchondral bone. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):419–33.
15. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil. 2006;14(1):13–29.
16. Safran MR, Seiber K. The evidence for surgical repair of articular cartilage in the knee. J Am Acad Orthop Surg. 2010;18(5):259–66.
17. Freed LE, Hollander AP, Martin I, Barry JR, Langer R, Vunjak-Novakovic G. Chondrogenesis in a cell-polymer-bioreactor system. Exp Cell Res. 1998;240(1):58–65. Important extended report on cartilage formation based on isolated cells cultured in a polymer scaffolds in bioreactors.
18. Schaefer D, Martin I, Jundt G, Seidel J, Heberer M, Grodzinsky A, et al. Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum. 2002;46(9):2524–34. First report on transplantation of tissue-engineered cartilage in an orthotopic animal model.
19. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331(14):889–95. First report on autologous chondrocyte implantation into articular cartilage defects in the knees of patients.
20. Brittberg M. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure. Am J Sports Med. 2009;38(6):1259–71.
21. Knutsen G, Drogset JO, Engebretsen L, Grontvedt T, Isaksen V, Ludvigsen TC, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am. 2007;89(10):2105–12.
22. Knutsen G, Engebretsen L, Ludvigsen TC, Drogset JO, Grontvedt T, Solheim E, et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am. 2004;86-A(3):455–64. First randomized trial comparing autologous chondrocyte implantation with microfracture.
23. Vanlauwe J, Saris DB, Victor J, Almqvist KF, Bellemans J, Luyten FP, TIG/ACT/01/2000&EXT Study Group. Five-Year Outcome of Characterized Chondrocyte Implantation Versus Microfracture for Symptomatic Cartilage Defects of the Knee: Early Treatment Matters. Am J Sports Med. 2011;39(12):2566–74. doi:10.1177/0363546511422220.
24. Pridie KH. A method of resurfacing osteoarthritic knee joints. Proceedings of the British Orthopaedic Association. J Bone Joint Surg (Br). 1959;41:618–9.
25. Steadman JR, Miller BS, Karas SG, Schlegel TF, Briggs KK, Hawkins RJ. The microfracture technique in the treatment of full-thickness chondral lesions of the knee in National Football League players. J Knee Surg. 2003;16(2):83–6.
26. Cucchiarini M, Madry H, Guilak F, Saris DB, Stoddart MJ, Koon Wong M, et al. A vision on the future of articular cartilage repair. Eur Cell Mater. 2014;27:12–6.
27. Madry H, Trippel SB. Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther. 2000;7(4):286–91.
28. Elsler S, Schetting S, Schmitt G, Kohn D, Madry H, Cucchiarini M. Effective, safe nonviral gene transfer to preserve the chondrogenic differentiation potential of human mesenchymal stem cells. J Gene Med. 2012;14(7):501–11.
29. Dinser R, Kreppel F, Zaucke F, Blank C, Paulsson M, Kochanek S, et al. Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes. Histochem Cell Biol. 2001;116(1):69–77.
30. Madry H, Cucchiarini M, Stein U, Remberger K, Menger MD, Kohn D, et al. Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid-mediated gene transfer in a gel suspension delivery system. J Gene Med. 2003;5(6):502–9.
31. Madry H, Cucchiarini M. Clinical potential and challenges of using genetically modified cells for articular cartilage repair. Croat Med J. 2011;52(3):245–61.
32. Madry H, Orth P, Cucchiarini M. Gene therapy for cartilage repair. Cartilage. 2011;2(3):201–25.
33. Johnstone B, Alini M, Cucchiarini M, Dodge GR, Eglin D, Guilak F, et al. Tissue engineering for articular cartilage repair–the state of the art. Eur Cell Mater. 2013;25:248–67.
34. Schinhan M, Gruber M, Vavken P, Dorotka R, Samouh L, Chiari C, et al. Critical-size defect induces unicompartmental osteoarthritis in a stable ovine knee. J Orthop Res. 2012;30(2):214–20.
35. Madry H, Kaul G, Zurakowski D, Vunjak-Novakovic G, Cucchiarini M. Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model. Eur Cell Mater. 2013;25:229–47. In-vivo proof-of concept that the combination of nonviral gene transfer with tissue engineering improves cartilage repair.
36. Johnstone B, Yoo JU. Autologous mesenchymal progenitor cells in articular cartilage repair. Clin Orthop. 1999;367 Suppl 156–62.
37. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238(1):265–72.
38. Benya PD, Padilla SR, Nimni ME. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell. 1978;15(4):1313–21.
39. Orth P, Weimer A, Kaul G, Kohn D, Cucchiarini M, Madry H. Analysis of novel nonviral gene transfer systems for gene delivery to cells of the musculoskeletal system. Mol Biotechnol. 2008;38(2):137–44.
40. Zhang HN, Leng P, Wang YZ, Zhang J. Treating human meniscal fibrochondrocytes with hIGF-1 gene by liposome. Clin Orthop Relat Res. 2009;467(12):3175–82.
41. Madry H, Zurakowski D, Trippel SB. Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation. Gene Ther. 2001;8(19):1443–9.
42. Madry H, Emkey G, Zurakowski D, Trippel SB. Overexpression of human fibroblast growth factor 2 stimulates cell proliferation in an ex vivo model of articular chondrocyte transplantation. J Gene Med. 2004;6(2):238–45.
43. Kaul G, Cucchiarini M, Arntzen D, Zurakowski D, Menger MD, Kohn D, et al. Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo. J Gene Med. 2006;8(1):100–11.
44. Schmal H, Mehlhorn AT, Zwingmann J, Muller CA, Stark GB, Sudkamp NP. Stimulation of chondrocytes in vitro by gene transfer with plasmids coding for epidermal growth factor (hEGF) and basic fibroblast growth factor (bFGF). Cytotherapy. 2005;7(3):292–300.
45. Cucchiarini M, Terwilliger EF, Kohn D, Madry H. Remodelling of human osteoarthritic cartilage by FGF-2, alone or combined with Sox9 via rAAV gene transfer. J Cell Mol Med. 2009;13(8B):2476–88.
46. Lohmander LS, Hellot S, Dreher D, Krantz EF, Kruger DS, Guermazi A, et al. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014;66(7):1820–31.
47. Sellers RS, Peluso D, Morris EA. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1997;79(10):1452–63.
48. Vogt S, Wexel G, Tischer T, Schillinger U, Ueblacker P, Wagner B, et al. The influence of the stable expression of BMP2 in fibrin clots on the remodelling and repair of osteochondral defects. Biomaterials. 2009;30(12):2385–92.
49. Hidaka C, Goodrich LR, Chen CT, Warren RF, Crystal RG, Nixon AJ. Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J Orthop Res. 2003;21(4):573–83.
50. Ha CW, Noh MJ, Choi KB, Lee KH. Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients. Cytotherapy. 2012;14(2):247–56.
51. Hsieh JL, Shen PC, Shiau AL, Jou IM, Lee CH, Wang CR, et al. Intraarticular gene transfer of thrombospondin-1 suppresses the disease progression of experimental osteoarthritis. J Orthop Res. 2010;28(10):1300–6.
52. Jeng L, Olsen BR, Spector M. Engineering endostatin-producing cartilaginous constructs for cartilage repair using nonviral transfection of chondrocyte-seeded and mesenchymal-stem-cell-seeded collagen scaffolds. Tissue Eng Part A. 2010;16(10):3011–21.
53. Evans CH, Robbins PD, Ghivizzani SC, Wasko MC, Tomaino MM, Kang R, et al. Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Natl Acad Sci U S A. 2005;102(24):8698–703.
54. Goodrich LR, Phillips JN, McIlwraith CW, Foti SB, Grieger JC, Gray SJ, et al. Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis. Mol Ther Nucleic Acids. 2013;2:e70.
55. Baragi VM, Renkiewicz RR, Jordan H, Bonadio J, Hartman JW, Roessler BJ. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J Clin Invest. 1995;96(5):2454–60. First study to reveal a protective effect of genetically modified chondrocytes transplanted onto human OA cartilage explants.
56. Hidaka C, Quitoriano M, Warren RF, Crystal RG. Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7. J Orthop Res. 2001;19(5):751–8.
57. Trippel SB, Corvol MT, Dumontier MF, Rappaport R, Hung HH, Mankin HJ. Effect of somatomedin-C/insulin-like growth factor I and growth hormone on cultured growth plate and articular chondrocytes. Pediatr Res. 1989;25(1):76–82.
58. van der Kraan PM, Buma P, van Kuppevelt T, van den Berg WB. Interaction of chondrocytes, extracellular matrix and growth factors: relevance for articular cartilage tissue engineering. Osteoarthr Cartil. 2002;10(8):631–7.
59. Madry H, Padera R, Seidel J, Langer R, Freed LE, Trippel SB, et al. Gene transfer of a human insulin-like growth factor I cDNA enhances tissue engineering of cartilage. Hum Gene Ther. 2002;13(13):1621–30. First study to reveal enhancement of chondrogenesis in a bioreactor by spatially defined nonviral overexpression of human IGF-I in cartilage tissue-engineering constructs.
60. Madry H, Rey-Rico A, Venkatesan JK, Johnstone B, Cucchiarini M. Transforming growth factor beta-releasing scaffolds for cartilage tissue engineering. Tissue Eng Part B Rev. 2014;20(2):106–25.
61. Heiligenstein S, Cucchiarini M, Laschke MW, Bohle RM, Kohn D, Menger MD, et al. Evaluation of nonbiomedical and biomedical grade alginates for the transplantation of genetically modified articular chondrocytes to cartilage defects in a large animal model in vivo. J Gene Med. 2011;13(4):230–42.
62. Heiligenstein S, Cucchiarini M, Laschke MW, Bohle RM, Kohn D, Menger MD, et al. In vitro and in vivo characterization of nonbiomedical- and biomedical-grade alginates for articular chondrocyte transplantation. Tissue Eng Part C Methods. 2011;17(8):829–42.
63. Goren A, Dahan N, Goren E, Baruch L, Machluf M. Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J. 2010;24(1):22–31.
64. Hauselmann HJ, Masuda K, Hunziker EB, Neidhart M, Mok SS, Michel BA, et al. Adult human chondrocytes cultured in alginate form a matrix similar to native human articular cartilage. Am J Physiol. 1996;271(3 Pt 1):C742–52.
65. Selmi TA, Verdonk P, Chambat P, Dubrana F, Potel JF, Barnouin L, et al. Autologous chondrocyte implantation in a novel alginate-agarose hydrogel: outcome at two years. J Bone Joint Surg (Br). 2008;90(5):597–604.
66. Almqvist KF, Dhollander AA, Verdonk PC, Forsyth R, Verdonk R, Verbruggen G. Treatment of cartilage defects in the knee using alginate beads containing human mature allogenic chondrocytes. Am J Sports Med. 2009;37(10):1920–9.
67. Madry H, Kaul G, Cucchiarini M, Stein U, Zurakowski D, Remberger K, et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther. 2005;12(14):1171–9. The study reveals the benefits of nonviral IGF-I overexpression in a hydrogel on articular-cartilage repair in vivo.
68. Capito RM, Spector M. Collagen scaffolds for nonviral IGF-1 gene delivery in articular cartilage tissue engineering. Gene Ther. 2007;14(9):721–32. Innovative study using a type II collagen–glycosaminoglycan scaffold as a nonviral gene-delivery vehicle.
69. Lu H, Lv L, Dai Y, Wu G, Zhao H, Zhang F. Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-beta1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation. PLoS One. 2014;8(7):e69950. Composite scaffold with DNA nanoparticles encoding TGF-ß1 extensively tested in vitro.
70. Lopa S, Madry H. Bioinspired scaffolds for osteochondral regeneration. Tissue Eng Part A. 2014. doi:10.1089/ten.tea.2013.0356.
71. Chen J, Chen H, Li P, Diao H, Zhu S, Dong L, et al. Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. Biomaterials. 2011;32(21):4793–805. Very interesting development of a biomimetic biphasic gene-activated osteochondral scaffold for spatially defined MSC chondro and osteogenesis.
72. Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1993;75(4):532–53.
73. Moutos FT, Guilak F. Composite scaffolds for cartilage tissue engineering. Biorheology. 2008;45(3–4):501–12.
74. Guo X, Zheng Q, Yang S, Shao Z, Yuan Q, Pan Z, et al. Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene. Biomed Mater. 2006;1(4):206–15.
75. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A. 2002;99(7):4397–402.
76. Deponti D, Di Giancamillo A, Mangiavini L, Pozzi A, Fraschini G, Sosio C, et al. Fibrin-based model for cartilage regeneration: tissue maturation from in vitro to in vivo. Tissue Eng Part A. 2012;18(11–12):1109–22.
77. Miot S, Brehm W, Dickinson S, Sims T, Wixmerten A, Longinotti C, et al. Influence of in vitro maturation of engineered cartilage on the outcome of osteochondral repair in a goat model. Eur Cell Mater. 2012;23:222–36.
78. Miot S, Scandiucci de Freitas P, Wirz D, Daniels AU, Sims TJ, Hollander AP, et al. Cartilage tissue engineering by expanded goat articular chondrocytes. J Orthop Res. 2006;24(5):1078–85.
79. Ball ST, Goomer RS, Ostrander RV, Tontz Jr WL, Williams SK, Amiel D. Preincubation of tissue engineered constructs enhances donor cell retention. Clin Orthop Relat Res. 2004;420(420):276–85.
80. Salzmann GM, Nuernberger B, Schmitz P, Anton M, Stoddart MJ, Grad S, et al. Physicobiochemical synergism through gene therapy and functional tissue engineering for in vitro chondrogenesis. Tissue Eng Part A. 2009;15(9):2513–24.
81. Mauck RL, Nicoll SB, Seyhan SL, Ateshian GA, Hung CT. Synergistic action of growth factors and dynamic loading for articular cartilage tissue engineering. Tissue Eng. 2003;9(4):597–611.
82. Kupcsik L, Stoddart MJ, Li Z, Benneker LM, Alini M. Improving chondrogenesis: potential and limitations of SOX9 gene transfer and mechanical stimulation for cartilage tissue engineering. Tissue Eng Part A. 2009;16(6):1845–55.
83. Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008;22(2):351–84.
84. Lefkoe TP, Trafton PG, Ehrlich M, Walsh WR, Dennehy DT, Barrach HJ, et al. An experimental model of femoral condylar defect leading to osteoarthrosis. J Orthop Trauma. 1993;7(5):458–67.
85. Rogachefsky RA, Dean DD, Howell DS, Altman RD. Treatment of canine osteoarthritis with insulin-like growth factor-1 (IGF-1) and sodium pentosan polysulfate. Osteoarthr Cartil. 1993;1(2):105–14.
86. Clemmons DR, Busby Jr WH, Garmong A, Schultz DR, Howell DS, Altman RD, et al. Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis. Arthritis Rheum. 2002;46(3):694–703.
87. Martel-Pelletier J, Di Battista JA, Lajeunesse D, Pelletier JP. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm Res. 1998;47(3):90–100.
88. Im GI, Jung NH, Tae SK. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng. 2006;12(3):527–36.
89. Longobardi L, O'Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, et al. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res. 2006;21(4):626–36.
90. Uebersax L, Merkle HP, Meinel L. Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release. 2008;127(1):12–21.
91. Madry H, Orth P, Kaul G, Zurakowski D, Menger MD, Kohn D, et al. Acceleration of articular cartilage repair by combined gene transfer of human insulin-like growth factor I and fibroblast growth factor-2 in vivo. Arch Orthop Trauma Surg. 2011;130(10):1311–22.
92. Evans CH, Ghivizzani SC, Robbins PD. Getting arthritis gene therapy into the clinic. Nat Rev Rheumatol. 2011;7(4):244–9.
93. Evans CH. Barriers to the clinical translation of orthopedic tissue engineering. Tissue Eng Part B Rev. 2011;17(6):437–41. Emphasizes barriers and strategies for the clinical translation of advanced orthopaedic tissue-engineering procedures.
94. Ivkovic A, Marijanovic I, Hudetz D, Porter RM, Pecina M, Evans CH. Regenerative medicine and tissue engineering in orthopaedic surgery. Front Biosci (Elite Ed). 2011;3:923–44.
95. Cucchiarini M, Thurn T, Weimer A, Kohn D, Terwilliger EF, Madry H. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthritis Rheum. 2007;56(1):158–67.
96. Freed LE, Martin I, Vunjak-Novakovic G. Frontiers in tissue engineering. In vitro modulation of chondrogenesis. Clin Orthop. 1999; 367 Suppl 46–58.
97. Angele P, Kujat R, Nerlich M, Yoo J, Goldberg V, Johnstone B. Engineering of osteochondral tissue with bone marrow mesenchymal progenitor cells in a derivatized hyaluronan-gelatin composite sponge. Tissue Eng. 1999;5(6):545–54.
98. Martin I, Miot S, Barbero A, Jakob M, Wendt D. Osteochondral tissue engineering. J Biomech. 2007;40(4):750–65.
99. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, et al. Engineering complex tissues. Tissue Eng. 2006;12(12):3307–39.
100. Stoddart MJ, Grad S, Eglin D, Alini M. Cells and biomaterials in cartilage tissue engineering. Regen Med. 2009;4(1):81–98.
101. Venkatesan JK, Ekici M, Madry H, Schmitt G, Kohn D, Cucchiarini M. SOX9 gene transfer via safe, stable, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to enhance the chondrogenic potential of human mesenchymal stem cells. Stem Cell Res Ther. 2012;3(3):22.
102. Rey-Rico A, Venkatesan JK, Sohier J, Moroni L, Cucchiarini M, Madry H. Adapted chondrogenic differentiation of human mesenchymal stem cells via controlled release of TGF-beta1 from poly(ethylene oxide)-terephtalate/poly(butylene terepthalate) multiblock scaffolds. J Biomed Mater Res A. 2014. doi:10.1002/jbm.a.35181.
103. Diekman BO, Christoforou N, Willard VP, Sun H, Sanchez-Adams J, Leong KW, et al. Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109(47):19172–7.
104. Willard VP, Diekman BO, Sanchez-Adams J, Christoforou N, Leong KW, Guilak F. Cartilage derived from mouse induced pluripotent stem cells for osteoarthritis drug screening in vitro. Arthritis Rheumatol. 2014. doi:10.1002/art.38780.
105. Ko JY, Kim KI, Park S, Im GI. In vitro chondrogenesis and in vivo repair of osteochondral defect with human induced pluripotent stem cells. Biomaterials. 2014;35(11):3571–81.
106. Lee J, Kim Y, Yi H, Diecke S, Kim J, Jung H, et al. Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2014;16(1):R41.
107. Driesang IM, Hunziker EB. Delamination rates of tissue flaps used in articular cartilage repair. J Orthop Res. 2000;18(6):909–11.
108. Madry H, Alini M, Stoddart MJ, Evans C, Miclau T, Steiner S. Barriers and strategies for the clinical translation of advanced orthopaedic tissue engineering protocols. Eur Cell Mater. 2014;27:17–21. discussion.
109. Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J. 2009;11(4):671–81.
110. Pinyon JL, Tadros SF, Froud KE ACYW, Tompson IT, Crawford EN, et al. Close-field electroporation gene delivery using the cochlear implant electrode array enhances the bionic ear. Sci Transl Med. 2014;6(233):233ra54.
111. Shepherd RK, Wise AK. Gene therapy boosts the bionic ear. Sci Transl Med. 2014;6(233):233fs17.
112. Madry H. Translating orthopaedic basic science into clinical relevance. J Exp Orthop. 2014;1(1):5.
113. Madry H, Weimer A, Kohn D, Cucchiarini M. Tissue engineering for articular cartilage repair improved by gene transfer. Current concepts. Orthopade. 2007;36(3):236–47.
114. Orth P, Kaul G, Cucchiarini M, Zurakowski D, Menger MD, Kohn D, et al. Transplanted articular chondrocytes co-overexpressing IGF-I and FGF-2 stimulate cartilage repair in vivo. Knee Surg Sports Traumatol Arthrosc. 2011;19(12):2119–30.
115. Katayama R, Wakitani S, Tsumaki N, Morita Y, Matsushita I, Gejo R, et al. Repair of articular cartilage defects in rabbits using CDMP1 gene-transfected autologous mesenchymal cells derived from bone marrow. Rheumatology (Oxford). 2004;43(8):980–5.
116. Che JH, Zhang ZR, Li GZ, Tan WH, Bai XD, Qu FJ. Application of tissue-engineered cartilage with BMP-7 gene to repair knee joint cartilage injury in rabbits. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):496–503.